
4-Bromo-2,6-dichlorophenol | CAS:3217-15-0
4-Bromo-2,6-dichlorophenol
- 名称:4-溴-2,6-二氯苯酚 | 4-Bromo-2,6-dichlorophenol
- CAS号:3217-15-0
- 别名:2,6-Dichloro-4-bromophenol
- 分子式:C6H3BrCl2O
- 分子量:241.90
- EINESC号:221-740-2
产品描述
物理化学性质
熔点 | 64-65 ºC |
---|---|
沸点 | 247 ºC |
闪点 | 103 ºC |
密度 | 1.890 |
安全数据
没有数据 | 没有数据 |
---|
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Structure-activity relationship studies of curcumin analogues.James R Fuchs et al.Bioorganic & medicinal chemistry letters, 19(7), 2065-2069 (2009-03-03)
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.Monika Sharma et al.Antimicrobial agents and chemotherapy, 53(8), 3256-3265 (2009-05-28)
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.Yunbao Liu et al.Journal of natural products, 73(7), 1193-1195 (2010-06-23)
Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.Xu Qiu et al.Bioorganic & medicinal chemistry, 16(17), 8035-8041 (2008-08-06)
Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.Chatchawan Changtam et al.European journal of medicinal chemistry, 45(10), 4446-4457 (2010-08-10)
Curcumin is a potent DNA hypomethylation agent.Zhongfa Liu et al.Bioorganic & medicinal chemistry letters, 19(3), 706-709 (2008-12-30)
Molecularly imprinted polymers for cleanup and selective extraction of curcuminoids in medicinal herbal extracts.Meyliana Wulandari et al.Analytical and bioanalytical chemistry, 407(3), 803-812 (2014-07-25)
Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis.P V Leyon et al.Journal of experimental & clinical cancer research : CR, 22(1), 77-83 (2003-05-03)
Efficiency of foam fractionation for the enrichment of nonpolar compounds from aqueous extracts of plant materials.Marlène Backleh-Sohrt et al.Journal of natural products, 68(9), 1386-1389 (2005-09-27)
Identification of curcumin derivatives as human glyoxalase I inhibitors: A combination of biological evaluation, molecular docking, 3D-QSAR and molecular dynamics simulation studies.Minggui Yuan et al.Bioorganic & medicinal chemistry, 19(3), 1189-1196 (2011-01-18)
A labdane diterpene glucoside from the rhizomes of Curcuma mangga.Faridah Abas et al.Journal of natural products, 68(7), 1090-1093 (2005-07-26)
Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder.W Chearwae et al.Biochemical pharmacology, 68(10), 2043-2052 (2004-10-13)
Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species.Chatchawan Changtam et al.European journal of medicinal chemistry, 45(3), 941-956 (2009-12-17)
Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.Milan Fiala et al.Proceedings of the National Academy of Sciences of the United States of America, 104(31), 12849-12854 (2007-07-27)
In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa.Jung Eun Kim et al.Phytotherapy research : PTR, 17(5), 481-484 (2003-05-16)
Structural investigation into the inhibitory mechanisms of indomethacin and its analogues towards human glyoxalase I.Ming Liu et al.Bioorganic & medicinal chemistry letters, 21(14), 4243-4247 (2011-06-22)
Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents.C Selvam et al.Bioorganic & medicinal chemistry letters, 15(7), 1793-1797 (2005-03-23)
Significant enhancement in radical-scavenging activity of curcuminoids conferred by acetoxy substituent at the central methylene carbon.Mi Kyoung Kim et al.Bioorganic & medicinal chemistry, 19(12), 3793-3800 (2011-05-24)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!